AIM-listed Metir plc (AIM:MET) provides fast-response mobile and point-of-use water and environmental testing technology. Its real-time water safety technology detects toxins in water preventing further downstream contamination.
It has also announced several strategic developments supporting the commercial advancement of its unique proprietary PFAS ‘forever chemicals’ detection platform across the UK, Europe and the US.
Chairman and chief executive is Bob Moore says the business has six potential revenue streams which have a common denominator. “Everything that we do works quickly and reacts quickly. That's our differentiator from the rest of the market.”
Several of the company’s products are being optimised including a device that can detect the water parasite cryptosporidium which Moore hopes will become available in 2027. Additionally, he hopes the PFAS testing business will be revenue generating in the next 12 months.
In this interview investors will learn:
- What problems Metir’s technology solves at a time water contamination is making international headlines
- How Metir’s Continuous Toxic Monitoring Device system in Qatar is a proof of concept for screening water for millions of people in capital cities
- What the potential size of the market is for PFAS testing
- Why Metir’s PFAS detector unit sale to Veralto, the $20bln market cap Nasdaq-listed water treatment enterprise, is a game-changing transaction
- How important the UK water and environmental field-testing market is to Metir’s growth strategy
- What other operational and commercial milestones the company aims to achieve before the end of 2026
Bob Moore, Chief Executive and Chairman of Metir (AIM:MET) was interviewed by Sarah Lowther for focusIR.
